Measuring Physical Function and Tolerability on Treatment in Patients With Hematologic Malignancies

被引：0
|
作者：
Major, Ajay [1 ]
Dueck, Amylou [2 ]
Thanarajasingam, Gita [3 ]
机构：
[1] Univ Colorado, Div Hematol, Dept Med, Sch Med, Aurora, CO 80045 USA
[2] Mayo Clin, Div Clin Trials & Biostat, Dept Quantitat Hlth Sci, Scottsdale, AZ 85259 USA
[3] Mayo Clin, Div Hematol, Rochester, MN 55906 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
Toxicity; tolerability; patient-reported outcomes; adverse events; physical function; symptoms; REPORTED OUTCOMES; CHEMOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S48 / S51
页数：4
相关论文
共 50 条
  • [1] Clinical Efficacy and Tolerability of Granulocyte Transfusions for the Treatment of Febrile Neutropenia in the Patients with Hematologic Malignancies
    Kim, Ki Hwan
    Lim, Hyo-Jeong
    Kim, Byung-Su
    Lee, Sang-Min
    Bang, Soo-Mee
    Kim, Inho
    Yoon, Sung-Soo
    Han, Kyou-Sup
    Park, Seonyang
    Kim, Byoung-Kook
    [J]. BLOOD, 2009, 114 (22) : 1222 - 1222
  • [2] Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies
    Schaffel, R
    Nucci, M
    Portugal, R
    Castro, MB
    Ferreira, SB
    Almeida, L
    Spector, N
    Pulcheri, W
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) : 821 - 822
  • [3] POLYMORPHONUCLEAR NEUTROPHIL (PMN) FUNCTION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    WHITED, S
    RAAB, S
    HAUT, A
    [J]. CLINICAL RESEARCH, 1975, 23 (01): : A21 - A21
  • [4] Mucositis In Patients With Hematologic Malignancies: Prophylaxis Or Treatment - That Is The Question!
    Pereira, Dulcineia
    Chacim, Sergio Pereira
    Martinez, Jose
    Mesquita, Edgar
    Sousa, Ines
    Martins, Angelo
    Mariz, Jose Mario
    [J]. BLOOD, 2013, 122 (21)
  • [5] Topotecan in the treatment of hematologic malignancies
    Beran, M
    Kantarjian, H
    [J]. SEMINARS IN HEMATOLOGY, 1998, 35 (03) : 26 - 31
  • [6] Immunotoxins in the treatment of hematologic malignancies
    Kreitman, Robert J.
    Pastan, Ira
    [J]. CURRENT DRUG TARGETS, 2006, 7 (10) : 1301 - 1311
  • [7] Evolution in the treatment of hematologic malignancies
    de Pauw, BE
    [J]. CURRENT OPINION IN ONCOLOGY, 2005, 17 (06) : 593 - 596
  • [8] The treatment of hematologic malignancies in pregnancy
    Vandenbriele, C.
    Dierickx, D.
    Amant, F.
    Delforge, M.
    [J]. FACTS VIEWS AND VISION IN OBGYN, 2010, 2 (02): : 74 - 87
  • [9] Bendamustine in the treatment of hematologic malignancies
    Diehl, V
    Cheson, BD
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (04) : 1 - 3
  • [10] CLADRIBINE FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES
    BALTZ, JK
    MONTELLO, MJ
    [J]. CLINICAL PHARMACY, 1993, 12 (11): : 805 - 813
12345